Volume 4 Number 3 November 2008

Jacques Puel memorial

• Serruys PW,
• Marco J

EuroInterv.2008;4:299

Together, we can truly insure the future

• Serruys PW

EuroInterv.2008;4:301

On acquiring decision making skills for endovascular interventions

• Lanzer P,
• Prechelt L

EuroInterv.2008;4:303-305

"Embargo" on scientific news, a late breaking message from the Ministry of Truth (MiniTrue)

• Wijns W

EuroInterv.2008;4:307-308

Interventional cardiology highlights of the European Society of Cardiology congress, 2008

• Van de Walle S,
• Kabir T,
• Zuffi A,
• Roguelov C,
• Eeckhout E

EuroInterv.2008;4:309-310

Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts

• van Twisk P-H,
• Daemen J,
• Kukreja N,
• van Domburg R,
• Serruys PW

EuroInterv.2008;4:311-317

Characterisation of the "vulnerable" coronary plaque by multi-detector computed tomography: a correlative study with intravascular ultrasound-derived radiofrequency analysis of plaque composition

• Sarno G,
• Vanhoenacker P,
• Decramer I,
• Schuijf J,
• Pundziute G,
• Margolis P,
• Gupta S,
• Bax J,
• Wijns W

EuroInterv.2008;4:318-323

Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents

• Garro N,
• Capodanno D,
• Cammalleri V,
• Tamburino C

EuroInterv.2008;4:324-330

The TandemHeart®, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience

• Vranckx P,
• Meliga E,
• de Jaegere P,
• van den Ent M,
• Regar E,
• Serruys PW

EuroInterv.2008;4:331-337

Long-term safety and efficacy are observed after implantation of Zotarolimus-Eluting Stent in real-world clinical practice

• Lee C-H,
• Low A,
• Hong E,
• Tai B-C,
• Lim I-H,
• Teo S-G,
• Lim Y-T,
• Tan H-C

EuroInterv.2008;4:338-344

"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents

• Presbitero P,
• Belli G,
• Zavalloni D,
• Rossi M,
• Lisignoli V,
• Barberis G,
• Gasparini G,
• Scatturin M,
• Morenghi E,
• Pagnotta P

EuroInterv.2008;4:345-350

Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

• de Jaegere P,
• Piazza N,
• Galema T,
• Otten A,
• Soliman O,
• Van Dalen B,
• Geleijnse M,
• Kappetein AP,
• García-García HM,
• Van Es G-A,
• Serruys PW

EuroInterv.2008;4:351-357

The "mini-crush technique" for the treatment of coronary trifurcation lesions

• Galassi A,
• Tomasello S,
• Sacchetta G,
• Seminara D,
• Canonico L,
• Tamburino C

EuroInterv.2008;4:358-364

Comparison of primary angioplasty in rural and metropolitan areas within an integrated network

• Giuliani G,
• Bonechi F,
• Vecchio S,
• Biondi-Zoccai G,
• Nieri M,
• Vittori G,
• Spaziani G,
• Nassi F,
• Chechi T,
• Di Mario C,
• Zipoli A,
• Margheri M

EuroInterv.2008;4:365-372

Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography

• Danesh Sani SH,
• Hasanzadeh M,
• Gholoobi A,
• Alimi H,
• Esmaily HA,
• Gifani M

EuroInterv.2008;4:373-377

A primer on the immune system in the pathogenesis and treatment of atherosclerosis

• Segers D,
• García-García HM,
• de Crom R,
• Krams R,
• Wentzel J,
• van der Steen A,
• Serruys PW,
• Leenen P,
• Laman J,
• Cheng C

EuroInterv.2008;4:378-390

Comparison of drug-eluting stent cell size using micro-CT: important data for bifurcation stent selection

• Mortier P,
• Van Loo D,
• De Beule M,
• Segers P,
• Taeymans Y,
• Verdonck P,
• Verhegghe B

EuroInterv.2008;4:391-396

Stent migration as a late complication following carotid angioplasty and stenting

• Castriota F,
• de Campos Martins E,
• Dall’Olmo C,
• Molnar R,
• Manetti R,
• Liso A,
• Oshoala K,
• Furgieri A,
• Ricci E,
• Cremonesi A

EuroInterv.2008;4:397-404

Intrepide™ Trapidil Eluting Stent

• Khan M,
• Mhulláin F,
• Nolan M

EuroInterv.2008;4:405-411